Biogen Inc. BIIB, +0.26% said in a statement that it stopped a post-marketing clinical trial testing its Alzheimer’s disease therapy Aduhelm, citing a Medicare policy that will limit usage of the drug. The company updated the study’s ClinicalTrials.gov listing with this information on Tuesday. The prospective, multi-center study planned to track patients taking Aduhelm for […]
Sanofi SNY, +5.95% SAN, +5.02% and GlaxoSmithKline GSK, +2.20% said Friday that their experimental bivalent COVID-19 booster had a 72% efficacy rate against omicron, and they now plan to submit the data to regulators. The recombinant protein booster protects against the original strain of the virus as well as the beta variant, a strain of […]
Reportedly, ongoing talks followed BlockFi signing a term sheet with FTX to secure a $250 million revolving credit facility on Tuesday. 1831 Total views 44 Total shares Crypto exchange FTX is reportedly in talks to acquire a stake in BlockFi after the company issued a $250 million credit to the lending firm. According to a […]
Shares of Zendesk Inc. ZEN, +27.99% soared 29.5% in premarket trading Friday, after the customer experience platform company confirmed a deal to be acquired by an investor group that includes Permira and Hellman & Friedman in an all-cash deal valued at about $10.2 billion. Under terms of the deal, the Permira and H&F will pay […]
A key part of the Central Bank’s role is the maintenance of monetary and financial stability. Our work on the first of these is primarily done through monetary policy set for the euro area by the ECB’s Governing Council. And here in Ireland we set out our views on the key risks to financial stability […]
Speech to Arthur Cox Client Seminar, 23 June 2022 Good afternoon. It is a pleasure to be here. Many thanks to Arthur Cox for inviting me to speak with you today. The focus of my remarks is the new Individual and Senior Executive Accountability framework which will come into effect next year1. I will […]